Product Information
BROMPHEN-PSE-DM 2-30-10 MG/5 ML is a generic product labeled by PAI Holdings LLC, priced at $0.0682 per ML under NDC 00121093316. Its NADAC has been published 226 times since Jun 8, 2022.
FDA first approved this application on Jul 21, 2014. Its Orange Book therapeutic-equivalence code is AA.
BROMPHEN-PSE-DM 2-30-10 MG/5 ML
Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan HydrobromideStrength
2; 10; 30 mg/5mL; mg/5mL; mg/5mL
Manufacturer
PAI Holdings LLCNDC
00121093316
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202940FDA Approved
7/21/2014
TE Code
AA
On Market Since
3/3/2022
Pharmacological Classes
Price Statistics
The NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has been published 226 times since Jun 8, 2022, and over the history we have for it it has risen 28.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0682 per ML |
|---|---|
| All-time high | $0.1053 (Dec 11, 2024) |
| All-time low | $0.0503 (Aug 17, 2022) |
| 52-week high | $0.0862 |
| 52-week low | $0.0682 |
| Median price | $0.0793 |
| Average price | $0.0782 |
| Largest weekly change | +25.9% (Nov 22, 2023) |
| Weeks tracked | 226 |
| Tracking since | Jun 8, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
PAI Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sigma-1 Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BROMPHEN-PSE-DM 2-30-10 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for BROMPHEN-PSE-DM 2-30-10 MG/5 ML, manufactured by PAI Holdings LLC, is $0.0682 per ML (NDC 00121093316), effective Sep 30, 2026.
How has the price of BROMPHEN-PSE-DM 2-30-10 MG/5 ML changed over time?
Over the history we have for it, the NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has risen 28.1%. It has been tracked across 226 weekly CMS publications since Jun 8, 2022.
What are the highest and lowest recorded NADAC prices for BROMPHEN-PSE-DM 2-30-10 MG/5 ML?
Since Jun 8, 2022, the NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has ranged from a low of $0.0503 (Aug 17, 2022) to a high of $0.1053 (Dec 11, 2024), with a median of $0.0793 per ML.
Are there cheaper alternatives to BROMPHEN-PSE-DM 2-30-10 MG/5 ML?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BROMPHEN-PSE-DM 2-30-10 MG/5 ML in a comparable dosage form, but none are currently priced below it.
Who manufactures BROMPHEN-PSE-DM 2-30-10 MG/5 ML?
BROMPHEN-PSE-DM 2-30-10 MG/5 ML (NDC 00121093316) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.